Immuno-Oncology NewsBristol-Myers, Nektar Developing Cancer Therapy to Be Used with Checkpoint InhibitorsImmuno-Oncology NewsThey will test the combo in advanced non-small cell lung cancer, kidney cancer, bladder cancer, melanoma, and triple negative b… Continue reading
Herald SunMelbourne scientists using stem cells, bio-engineering to treat pelvic organ prolapse in mothersHerald Sun“For women who have already got a prolapse we are aiming to use cells with nanobiomaterials to provide support while the damaged tissue … Continue reading
Phys.OrgWhat happens when you put evolution on replay?Phys.Org"This work will help us in understanding the limits of life by combining synthetic biology and evolutionary biology," she says. "In this way, we can approach wider problems in… Continue reading
|
Molecular Assemblies Expands Leadership Team with Appointment of Vice President of Chemistry and Biochemistry
Markets Insider Molecular Assemblies, Inc. is a San Diego-based company focused on developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature … |
pharmaphorum |
Prokarium raises $10m for ‘game changer’ synthetic bio vaccines
pharmaphorum UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation of vaccines, which could be taken orally, and not have to be kept in a refrigerator. The new funding will allow Prokarium to … Prokarium Secures $10 Million for Clinical Development of Revolutionary Thermostable VaccinesTechnology Networks Prokarium Secures $10 Million Investment from Saudi, Swedish and Korean Investors for Clinical Development of …Business Wire (press release) |